Why Vitamin D Alone Isn't Enough: The Cofactors That Make It Work

magnesium vitamin d vitamin k2 Jul 13, 2026
Nutrients & Co-Factors

Why Vitamin D Alone Isn't Enough: The Cofactors That Make It Work

By Michael Rutherford

Vitamin D is the most-supplemented nutrient in functional health — and one of the most commonly misunderstood. A vitamin D level can't be read in isolation, and a low one often can't be corrected by simply adding more D. Two cofactors determine whether vitamin D actually works, and whether it works safely: magnesium and vitamin K2.

The Problem With Reading Vitamin D in Isolation

Most low vitamin D results are treated as a simple supply problem: the number is low, so add more vitamin D. But in functional practice, the majority of low 25(OH)D values are not straightforward vitamin D deficiencies at all. They reflect something further upstream or downstream — a conversion problem, an inflammatory process, a calcium issue, or a cofactor shortage. Reading the number without asking why it's there is how the same clients end up on escalating doses of vitamin D that never quite move the needle.

Two cofactors sit at the center of this story. One determines whether vitamin D can be activated in the first place. The other determines whether the calcium vitamin D absorbs ends up helping or harming. Miss either, and vitamin D supplementation becomes at best ineffective and at worst counterproductive.

Magnesium: The Cofactor That Activates Vitamin D

Vitamin D is biologically inert when it arrives, whether synthesized in the skin from sunlight or swallowed as a supplement. To become useful, it undergoes two hydroxylation steps: the liver converts it to 25-hydroxyvitamin D — the form measured on a standard lab — and the kidney converts that into 1,25-dihydroxyvitamin D, the active hormone. The enzymes driving both conversions, along with the vitamin D binding protein that transports it, are magnesium-dependent.1

The foundational research here is decades old and unambiguous: magnesium deficiency impairs the conversion of 25(OH)D into the active 1,25(OH)₂D, producing a state of functional vitamin D deficiency even when intake and stores appear adequate.2 More recent work confirms and extends it — a randomized trial demonstrated that magnesium status directly influences vitamin D metabolism, and large population data show magnesium intake significantly modifies the relationship between vitamin D and health outcomes.3,4 In other words, the same dose of vitamin D behaves differently depending on whether magnesium is present to activate it.

This reframes a huge number of "vitamin D deficiencies." A client who doesn't respond to vitamin D supplementation, whose level stubbornly refuses to climb, is frequently not short on vitamin D — they're short on the magnesium required to process it. And there's a compounding trap: metabolizing supplemental vitamin D consumes magnesium, so pushing high-dose D into an already magnesium-depleted person can deepen the very deficiency driving the problem.1

Clinical Pearl: When a vitamin D level won't rise despite consistent supplementation, the bottleneck is often magnesium, not vitamin D. The lab says D; the limiting factor is the cofactor. Adding more of what can't be activated doesn't address why it isn't being activated.

Learn to read vitamin D — and 50+ markers.

Blood Chemistry 101 gives you the foundational framework for reading any panel in context.

Explore BC101 →

Why Serum Magnesium Won't Tell You the Truth

If magnesium is this central, the obvious move is to test it — but here practitioners hit a second trap. Serum magnesium, the version on a standard panel, is a poor reflection of true magnesium status. The body tightly defends the blood concentration, pulling magnesium from tissue and bone to keep serum in range, so serum can read perfectly normal while the client is meaningfully depleted at the tissue level.5 RBC magnesium is the far more informative marker when status is in question. Judging a client's magnesium — and therefore their capacity to activate vitamin D — by serum alone will reassure you at exactly the wrong moment. Subclinical magnesium deficiency is common, frequently silent on standard panels, and increasingly recognized as a driver of the very cardiovascular and metabolic problems practitioners hope vitamin D will help address.5

Vitamin K2: The Cofactor That Directs the Calcium

The second cofactor addresses a different question entirely: not whether vitamin D works, but where its effects land. One of vitamin D's primary roles is to increase intestinal calcium absorption. Vitamin D is very good at getting calcium into the bloodstream — but it exerts no control over where that calcium subsequently goes. That direction is the job of vitamin K2.

Vitamin K2 activates two key calcium-regulating proteins through carboxylation: osteocalcin, which binds calcium into the bone matrix, and matrix Gla protein, which actively inhibits calcium from depositing in arterial walls and soft tissue.6 Without adequate K2, these proteins remain inactive, and the calcium vitamin D worked so hard to absorb is left undirected. The consequence is the central concern of the vitamin D–K2 relationship: raising vitamin D — particularly at high intakes — without sufficient K2 can promote the deposition of calcium in precisely the places it shouldn't go, contributing to arterial and soft-tissue calcification.6,7

This is why vitamin D and K2 are best understood as partners rather than separate supplements. Vitamin D opens the door for calcium; K2 makes sure it walks into bone rather than blood vessels. Aggressively supplementing D while neglecting K2 doesn't just leave benefit on the table — it can actively redirect risk.

More Isn't the Answer

Put the two cofactors together and a clear principle emerges: the goal with vitamin D is not the highest number possible, but a sufficient, well-cofactored level. This matters because the reflexive functional-medicine move — escalating vitamin D doses in pursuit of an ever-higher lab value — runs directly against the physiology. Large randomized data have failed to show that simply pushing vitamin D higher delivers the cardiovascular and mortality benefits once assumed,8 and the cofactor picture explains why: vitamin D given without magnesium may not activate, and vitamin D given without K2 may misdirect calcium. Optimal 25(OH)D sits around 30–60 ng/mL — a range to reach thoughtfully, with cofactors in view, not to blow past with megadoses.

For the practitioner, this changes the entire approach to a low vitamin D result. Rather than reaching immediately for a higher dose, the questions become: Is magnesium status adequate to activate what's already there? Is K2 present to direct the calcium D will absorb? Is this low number even a vitamin D problem, or a magnesium one wearing a vitamin D label? This is the same contextual reading that underlies why low vitamin D doesn't always mean deficiency, and the broader discipline of pattern recognition across markers.

Supporting the terrain — magnesium and K2 status, alongside vitamin D — sits well within scope through nutrition and lifestyle. As always, the aim is to support and educate, to investigate the root of a stubborn value rather than override it with dose, and to refer when findings warrant it.

Newly Revamped · Available Now

Blood Chemistry 101

Vitamin D is a perfect example of why a marker can't be read alone. Blood Chemistry 101 teaches the Three-Tier Decision Tree, pattern recognition, and a root-cause approach across 50+ markers — the foundation for reading any panel in context — in a course you can complete in a single weekend.

Explore Blood Chemistry 101

For health coaches, NTPs, FDN-Ps, and nutrition professionals.

Frequently Asked Questions

Why won't my client's vitamin D rise despite supplementing?

Magnesium is a frequent culprit. Vitamin D must be activated through two magnesium-dependent conversion steps, so when magnesium is low, supplemental vitamin D can't be efficiently processed and the level stays stubbornly low. In these cases the result reflects a cofactor bottleneck rather than insufficient vitamin D, and adding more D without addressing magnesium tends not to help.

Why should vitamin K2 be paired with vitamin D?

Vitamin D increases calcium absorption but doesn't determine where the calcium goes. Vitamin K2 activates the proteins that direct calcium into bone and inhibit its deposition in arteries and soft tissue. Raising vitamin D without adequate K2 can leave that absorbed calcium poorly directed, which is why the two nutrients are considered partners rather than separate supplements.

Is serum magnesium a reliable test?

Not for detecting subtle or subclinical deficiency. The body defends serum magnesium by drawing from tissue stores, so serum can appear normal while the client is genuinely depleted. RBC magnesium is a more informative marker when magnesium status — and therefore vitamin D activation capacity — is in question.

What is an optimal vitamin D level?

A functional optimal 25(OH)D generally sits around 30–60 ng/mL. The objective is a sufficient, well-cofactored level rather than the highest possible number, since very high vitamin D without adequate magnesium and K2 can be both ineffective and, through misdirected calcium, potentially harmful.

Can high-dose vitamin D be harmful?

It can, particularly without cofactors. Sustained high intakes without adequate K2 can promote calcium deposition in arteries and soft tissue, and high-dose vitamin D also draws down magnesium. This is why the functional approach favors reaching an optimal range with cofactor support rather than pursuing ever-higher levels through dose alone.

References

  1. Uwitonze, A. M., & Razzaque, M. S. (2018). Role of magnesium in vitamin D activation and function. Journal of the American Osteopathic Association, 118(3), 181-189. https://doi.org/10.7556/jaoa.2018.037
  2. Rude, R. K., Adams, J. S., Ryzen, E., Endres, D. B., Niimi, H., Horst, R. L., … Singer, F. R. (1985). Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiency. Journal of Clinical Endocrinology and Metabolism, 61(5), 933-940. https://doi.org/10.1210/jcem-61-5-933
  3. Dai, Q., Zhu, X., Manson, J. E., Song, Y., Li, X., Franke, A. A., … Shrubsole, M. J. (2018). Magnesium status and supplementation influence vitamin D status and metabolism: Results from a randomized trial. American Journal of Clinical Nutrition, 108(6), 1249-1258. https://doi.org/10.1093/ajcn/nqy274
  4. Deng, X., Song, Y., Manson, J. E., Signorello, L. B., Zhang, S. M., Shrubsole, M. J., … Dai, Q. (2013). Magnesium, vitamin D status and mortality: Results from US NHANES 2001 to 2006 and NHANES III. BMC Medicine, 11, 187. https://doi.org/10.1186/1741-7015-11-187
  5. DiNicolantonio, J. J., O'Keefe, J. H., & Wilson, W. (2018). Subclinical magnesium deficiency: A principal driver of cardiovascular disease and a public health crisis. Open Heart, 5(1), e000668. https://doi.org/10.1136/openhrt-2017-000668
  6. van Ballegooijen, A. J., Pilz, S., Tomaschitz, A., Grübler, M. R., & Verheyen, N. (2017). The synergistic interplay between vitamins D and K for bone and cardiovascular health: A narrative review. International Journal of Endocrinology, 2017, 7454376. https://doi.org/10.1155/2017/7454376
  7. Theuwissen, E., Smit, E., & Vermeer, C. (2012). The role of vitamin K in soft-tissue calcification. Advances in Nutrition, 3(2), 166-173. https://doi.org/10.3945/an.111.001628
  8. Barbarawi, M., Kheiri, B., Zayed, Y., Barbarawi, O., Dhillon, H., Swaid, B., … Manson, J. E. (2019). Vitamin D supplementation and cardiovascular disease risks in more than 83,000 individuals in 21 randomized clinical trials: A meta-analysis. BMJ, 366, l4673. https://doi.org/10.1136/bmj.l4673